Share price: 112.80p

Issue of Equity

16th September 2013

Cello Group plc (the “Group” or the “Company”)

Additional listing / TVR

The Company announces that on 13 September 2013 it resolved to issue 196,188 new ordinary shares of 10p each to vendors of a business previously acquired by the Group. These shares are to be issued pursuant to the share purchase agreement in relation to Mash Healthcare Group Limited

Application has been made for these shares to be admitted to trading on AIM and admission is expected to occur on 19 September 2013. The Company’s issued share capital, following the admission of the 196,188 new shares, will be 83,072,552 ordinary shares of 10 pence each (“Ordinary Shares”), all with voting rights. The Company holds 381,000 Ordinary Shares in treasury at the date of this announcement. The total number of current voting rights in the Company will therefore be 82,691,552 shares.

The above figure (82,691,552 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA’s Disclosure and Transparency Rules.

13 September 2013

For further Information please contact:

Cello Group plc
Mark Scott, Chief Executive                       020 7812 8460
Mark Bentley, Group Finance Director

Cenkos Securities plc
Bobbie Hilliam                                               020 7397 8900

 

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150